Across TCGA pan-cancer cohorts, LINC01201 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01201’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where LINC01201 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01201 is over-expressed in tumor.
THCA are the cancer types where LINC01201 tumor–normal differential expression is most reproducible.